Archive for November, 2016

One research found out that the risk of high blood pressure was linked to kidneys that are smaller-than-normal at birth. A different study done within the same field arrived at the finding that high blood pressure and impaired cells had some form of association.

Dr. Anne Monique Nuyt, who co-authored both studies, studies said that these studies are a pointer of how vital it is to follow up the health of preterm babies. Anne is a University of Montreal professor working within the department of pediatrics.

People who were given the 2-dose Shingrix vaccine recorded an 88 percent reduction in the risks of developing shingles, four years after vaccination. When the stage was approaching its final trial, there was a reduction of 91 percent. That is according to results published in the New England Journal of Medicine. People aged more than 70 years recorded effectiveness of 90 percent after they received the injection.

Clinical trials of GSK indicated greater protection of elderly patients compared to the patients injected with Merck & Co’s rival Zostavax vaccine. This drug is one of those that GSK has placed most of its hope. It has plans to make an application for the U.S., European and Japanese approval later on this year. The first the market may start getting it will be in 2017.
The New England Journal of Medicine has got the latest four-year data on Shingrix. This data may be a big boost in offering an additional significant advantage as its effectiveness is kept constant overtime.

According to the study, contrary to short naps or failing to nap, the sugar level in the blood goes up by 45 percent if you take a nap of more than one hour. The researchers further suggest that for a nap lasting less than one hour, all these risks disappear.

The director of the Clinical Diabetes Center at Montefiore Medical Center in New York City, Dr. Joel Zonszein, said that it is interesting to discover the possibility of long daytime naps and type 2 Diabetes being related. Zonszein went on to add that people should be notified of this study and the findings. They should understand that the results are just makers of lifestyles and not the cause of diabetes. He did not take part in the study.

The research findings were presented at the European Association for the Study of Diabetes meeting in Munich, Germany.